Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Titel:
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Auteur:
Shin, Dong-Yeop Park, Sahee Jang, Eunjung Kong, Jee Hyun Won, Young-Woong Oh, Sukjoong Choi, Yunsuk Kim, Jeong-A Lee, Se Won Mun, Yeung-Chul Kim, Hawk Kim, Sung-Hyun Rok Do, Young Kwak, Jae-Yong Kim, Hyeoung-Joon Zang, Dae Young Lim, Sung-Nam Lee, Won Sik Kim, Dong-Wook